Friday, July 10, 2026

pharma · HIV Infections · HIV-1 infection

ViiV Healthcare Pty

ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, HIV-1 infection, Human immunodeficiency virus (HIV), human immunodeficiency virus (HIV). NovaP

London, GB HQ
2009 Founded
1,906 Employees
TGA registrant Type
Company details
Status
Public
HQ
London, GB
Founded
2009
Employees
1,906
Programs
10
Drugs
27
Patents
0

Quick answer

ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, HIV-1 infection, Human immunodeficiency virus (HIV), human immunodeficiency virus (HIV). NovaPharmaNews links 10 clinical program(s), 10 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (4), phase 3 (4), phase 1 (2).

Company snapshot

We are ViiV Healthcare: the only global pharmaceutical company 100% dedicated to preventing, treating and curing HIV. Unafraid to be first, we push the boundaries of what people think is possible – bringing together our transformational science and a deep understanding of the communities we serve – all to reach a HIV-free generation and ultimately, make HIV history. For job opportunities, please v

  • 11 approved product(s) across US/EU regulatory metadata.
  • 10 active pipeline program(s) linked via ClinicalTrials.gov.
  • 10 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for ViiV Healthcare Pty. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum

Proprietary activity score for ViiV Healthcare Pty.

0 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 0 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for ViiV Healthcare Pty.

  1. Clinical update

    219816 — Phase 3

  2. Clinical update

    219700 — Phase 3

  3. Clinical update

    218307 — Phase 2

  4. Clinical update

    212580 — Phase 2

  5. Clinical update

    222638 — Phase 2

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is ViiV Healthcare Pty?

    ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, HIV-1 infection, Human immunodeficiency virus (HIV), human immunodeficiency virus (HIV). NovaPharmaNews links 10 clinical program(s), 10 drug profile(s),

  • Is ViiV Healthcare Pty publicly traded?

    ViiV Healthcare Pty appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does ViiV Healthcare Pty develop or market?

    We link 27 drug profile(s) where ViiV Healthcare Pty is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/viiv-healthcare-bv#company-drugs.

  • What are the latest developments for ViiV Healthcare Pty?

    In the last 12 months our linked public records show 10 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does ViiV Healthcare Pty focus on?

    ViiV Healthcare Pty focuses on HIV Infections, HIV-1 infection, Human immunodeficiency virus (HIV) based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Infectious Disease
22